
### [NCIT:C3898](http://purl.obolibrary.org/obo/NCIT_C3898)
**Label:** Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

**Subclasses:** [NCIT:C5635](http://purl.obolibrary.org/obo/NCIT_C5635) (Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C5768](http://purl.obolibrary.org/obo/NCIT_C5768) (Liver Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C27763](http://purl.obolibrary.org/obo/NCIT_C27763) (Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C45163](http://purl.obolibrary.org/obo/NCIT_C45163) (Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C45166](http://purl.obolibrary.org/obo/NCIT_C45166) (Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C5088](http://purl.obolibrary.org/obo/NCIT_C5088) (Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C5264](http://purl.obolibrary.org/obo/NCIT_C5264) (Bronchial Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C5089](http://purl.obolibrary.org/obo/NCIT_C5089) (Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C5266](http://purl.obolibrary.org/obo/NCIT_C5266) (Gastric Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C44960](http://purl.obolibrary.org/obo/NCIT_C44960) (Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C95991](http://purl.obolibrary.org/obo/NCIT_C95991) (Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C5498](http://purl.obolibrary.org/obo/NCIT_C5498) (Colon Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C7230](http://purl.obolibrary.org/obo/NCIT_C7230) (Primary Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C5085](http://purl.obolibrary.org/obo/NCIT_C5085) (Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C5086](http://purl.obolibrary.org/obo/NCIT_C5086) (Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C5087](http://purl.obolibrary.org/obo/NCIT_C5087) (Stage III Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C95626](http://purl.obolibrary.org/obo/NCIT_C95626) (Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C5090](http://purl.obolibrary.org/obo/NCIT_C5090) (Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C35688](http://purl.obolibrary.org/obo/NCIT_C35688) (Breast Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C123394](http://purl.obolibrary.org/obo/NCIT_C123394) (Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C96506](http://purl.obolibrary.org/obo/NCIT_C96506) (Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C35689](http://purl.obolibrary.org/obo/NCIT_C35689) (Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 54.38%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma))) 37.02%


